Bornstein Jeffrey S

Row 1 · 2026-07-21 · Exercise / conversion · Acquired 9,558 · Balance 143,806

F1: Represents the conversion of a subscription right issued by the Issuer as part of a rights offering that closed on July 21, 2026 (the "Rights Offering"). Each subscription right was exercisable for units that consisted of (i) 1 share of common stock and (ii) 0.4388 of a warrant exercisable to acquire a share of common stock at an exercise price of $5.48 per share.

Row 3 · 2026-07-21 · Exercise / conversion · Disposed 9,558 · Balance 0

F1: Represents the conversion of a subscription right issued by the Issuer as part of a rights offering that closed on July 21, 2026 (the "Rights Offering"). Each subscription right was exercisable for units that consisted of (i) 1 share of common stock and (ii) 0.4388 of a warrant exercisable to acquire a share of common stock at an exercise price of $5.48 per share.

Row 4 · 2026-07-21 · Exercise / conversion · Acquired 4,194 · Balance 4,194

F1: Represents the conversion of a subscription right issued by the Issuer as part of a rights offering that closed on July 21, 2026 (the "Rights Offering"). Each subscription right was exercisable for units that consisted of (i) 1 share of common stock and (ii) 0.4388 of a warrant exercisable to acquire a share of common stock at an exercise price of $5.48 per share.

F2: Warrants became exercisable immediately after the Rights Offering closed and expire 10 years later, unless exercised or redeemed earlier. If a warrant is not exercised or redeemed before it expires, it will have no value.

Row 2 · Balance 1,500

Row 1 · 2017-11-06 · Exercise / conversion · Acquired 7,400 · Balance 192,183

Row 2 · 2017-11-06 · Tax withholding · Disposed 3,538 · Balance 188,645

Row 4 · 2017-11-06 · Exercise / conversion · Disposed 7,400 · Balance 22,200

F1: 1 for 1

Row 3 · Balance 41,152

Row 1 · 2024-06-06 · Grant · Acquired 35,000 · Balance 110,197

F1: The shares reported in this transaction represent Restricted Stock Units ("RSUs") issued under the AlloVir, Inc. 2020 Stock Option and Grant Plan. Each RSU represents the contingent right to receive one share of the Issuer's Common Stock. The shares shall vest upon the earlier to occur of (i) June 6, 2025 and (ii) the next annual meeting of the Issuer's stockholders, subject to the Reporting Person's continued service on the Issuer's Board of Directors.

Row 1 · Balance Not disclosed

F1: As described in the issuer's registration statement on Form S-1 (File No. 333-252484) (the "Registration Statement") under the heading "Description of Securities - Founder Shares", the Class B ordinary shares will automatically convert into Class A ordinary shares on a one-for-one basis on the first business day following the consummation of the issuer's initial business combination, subject to adjustment as described in the Registration Statement. The Class B ordinary shares have no expiration date.

F2: Shares held by Whipstick Ventures, LLC. The reporting person has a controlling interest in Whipstick Ventures, LLC and may be deemed to beneficially own these securities. The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all the reported shares for purposes of Section 16 or for any other purpose.